1. Infection
1.1. Bacteria
1.1.1. Antibiotic Resistance
1.1.1.1. Pseudomonas aeruginosa
1.1.2. Type IV pili
1.1.2.1. Movement and Infection
1.1.2.2. Molecular grappling hooks
1.1.2.3. Chemotaxis
1.1.2.4. Single protein
1.1.2.5. Multiprotein complex
1.2. Molecular thermostat
2. Viral Inflections and Host Responses
2.1. Immune System
2.2. Microorganisms
2.2.1. Bacteria
2.2.2. Viruses
2.2.3. Fungi
2.2.4. Parasites
2.3. Avian Influenza Virus
2.3.1. Application of TLR ligands in chickens
2.3.1.1. Route of administration
2.3.1.2. Time
2.3.1.3. Synergistic or antagonistic effect
3. Antibacterial Drug Discovery
3.1. 1930's The sulfonamides
3.1.1. Gerhard Domagk
3.2. The accidental discovery of Pencillin
3.2.1. Sir Alexander Fleming, Ernst Chain, Howard Florey, Dorothy Hodgkin
3.3. The 'Golden Age' of antibacterial drug discovery
3.3.1. Selman Waksman
3.3.1.1. Streptomycin(1943)
3.4. Antibiotic Targets
3.5. Antibiotic Resistance
3.6. Misuse and overuse of antibiotics
3.7. The cost of antibiotic resistance
4. Gut Bacteria
4.1. Gut Microbiome
4.1.1. Antimicrobial
4.1.2. Nutrient Metabolism
4.1.3. Support Immune System
4.1.4. Maintain Integrity of Gut Barrier
4.2. Bacterial Digestive System
4.3. Vesicles
4.4. Secretion System
4.4.1. Bacterial Dagger
4.4.2. Molecular Syringe
4.5. Crohn's Disesas
4.5.1. Genetics
4.5.2. Gut Bacteria
4.5.3. Infectious Gastroenteritis
4.5.4. Environmental Factors
5. Membranes
5.1. Drug targets
5.1.1. Cell death
5.2. Basic concept
5.2.1. Fluid mosaic model
5.2.2. Lipid bilayer
5.2.2.1. Phospholipid Asymmety
5.2.2.1.1. Blood coagulation
5.2.2.1.2. Apoptosis
5.3. Action
5.3.1. Diacyglycerol kinases (DGKs)
5.3.1.1. Linkers
5.3.1.2. Lipid carrie
6. Herpesviruses
6.1. Alphaher Persviruses
6.2. Betaherpsviruses
6.3. Gammaherpeviruses
7. Novel Mouse Models Of Diabetes-Induced Accelerated Atherosclerosis
7.1. Diabetes Mellitus
7.2. The Vascular Complications of DM
7.2.1. Micronascular
7.2.2. Macrovascular
7.3. Atherosclerosis
7.4. ApoE-/- mouse
7.5. Akita miuse
7.6. Evaluating the atherosclerotic lesions
7.7. Metabolic Parameters
7.8. Aortic Sinus and Ascending Aorta
7.9. Brachiocephalic Artery
7.10. Coronary Arteries
7.11. Myocardial complications
8. Viruses
8.1. Human cancer
8.1.1. Immortalized cells
8.1.1.1. Cellular pathways
8.1.1.1.1. Cell cycle
8.1.1.1.2. Cytoskeletal
8.1.1.1.3. Insulin growth factor related
8.1.1.1.4. Interferon related
8.1.1.1.5. MAP kinase
8.1.1.1.6. Oxidative stress
8.1.2. Transformed or cancer cells
8.2. Anti-proliferative
8.3. Anti-viral
8.4. Oncolytic viruses
8.4.1. Preferentially replicate
8.4.2. Kill tumor cells
8.4.3. Anti-tumor immune
8.5. Herpesviruses
8.5.1. HSV-1
8.5.1.1. Normal and tumor cells
8.5.2. BHV-1
8.5.2.1. Virus replication and toxicity
9. Diabetes
9.1. Obesity
9.1.1. insulin resistance
9.1.1.1. immunometabolism
9.1.1.1.1. immune system
9.2. diet
9.2.1. microbiota
10. Cell
10.1. Adaptive immune system
10.1.1. Cancer
10.1.1.1. Interferons
10.1.1.1.1. HIV